Economy · Finance
Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion
CNBC · World
Published 2 Oct 2026, 10:31 pm·5 d ago·1 min read
Listen to this story
Read aloud by your device
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
Read the full story at CNBC · World
cnbc.com